Predicting response to sepantronium bromide (YM155), a survivin suppressant, by PET imaging with [C-11]YM155

Mitsuoka, K; Kita, A; Murakami, Y; Shirasuna, K; Noda, A; Yamanaka, K; Kaneko, N; Miyoshi, S

Miyoshi, S (reprint author), Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.

NUCLEAR MEDICINE AND BIOLOGY, 2018; 64-65 (): 41

Abstract

Introduction: Sepantronium bromide (YM155) is a survivin suppressant that induces apoptosis in tumor cells. Although YM155 induces tumor regression in......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索